FDA Approved: PEMETREXED — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for pemetrexed disodium from Sagent Pharmaceuticals, enabling continued availability of this generic anticancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

SUPPL AP for PEMETREXED (PEMETREXED DISODIUM)